Brinkley David L 4
4 · THERAVANCE INC · Filed May 31, 2013
Insider Transaction Report
Form 4
THERAVANCE INCTHRX
Brinkley David L
Head of Business Dev.
Transactions
- Sale
Common Stock
2013-05-29$35.01/sh−3,808$133,318→ 48,749 total
Footnotes (2)
- [F1]DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
- [F2]This transaction was executed in multiple trades at prices ranging from $34.99 to $35.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.